CHICAGO (GenomeWeb) – Genome informatics vendor DNAnexus and variant analysis software company Saphetor are integrating their technologies in hopes of creating a seamless platform for genome-based biomarker discovery and interpretation.
Users can now access Saphetor's technology to annotate and classify variants from next-generation sequencing directly from the DNAnexus cloud platform, the two companies said. Saphetor performs whole-genome analysis by running NGS results through a database of 33 billion variant annotation points.
"Together with the scalability and high-performance computing power of the DNAnexus platform, and Saphetor’s variant browsing tools, customers can quickly move from NGS data analysis to interpretation," DNAnexus scientist Chai Fungtammasan wrote in a blog post. "Researchers can discover which variants have a functional impact on disease in the hopes of accelerating the implementation of precision medicine."